Building a Unified Solutions Roadmap for a Global Health Innovation Company
\ CASE STUDY
IN PARTNERSHIP WITH
"We worked with C\R Strategy Partners at a time of rapid business change to align our leadership team around execution of next-stage strategies. Frances and her team partnered with us to focus on the market and operational opportunities that will help us maintain our 20+ years of growth.”
— Jim Weiss, Founder and Chairman, Real Chemistry
Background
Real Chemistry is a global health innovation company dedicated to making medicine more human. Serving the world's leading biopharma companies, Real Chemistry integrates data science, technology, communications, and consulting to help clients navigate the full complexity of modern healthcare, from clinical development through commercial launch and beyond.
Over more than two decades, Real Chemistry grew into a multifaceted organization with deep capabilities across a wide range of disciplines. That breadth was a competitive advantage, but it also created strategic tension. With multiple specialized business units operating with their own identities, processes, and go-to-market strategies, the company faced a defining question: how do you bring the full power of an integrated platform to clients when your capabilities are not fully connected to one another?
Real Chemistry engaged C\R Strategy Partners at a moment of rapid business change. The goal was to align the leadership team around a shared vision, develop an integrated solutions roadmap, and build the internal structures needed to deliver on the promise of a unified company, while still sustaining the growth trajectory that had defined the company for over 20 years.
The Challenge
Real Chemistry's growth had created a powerful but complex organization. Translating that complexity into integrated client value required solving five interlocking challenges:
-
Fragmented capabilities: Multiple specialized business units had developed distinct cultures, processes, and client relationships, making it difficult to present and deliver a cohesive, integrated offering across the full platform.
-
No shared roadmap: Without a unified solutions strategy, individual units operated with their own priorities and definitions of success which limited cross-functional collaboration and left significant value unrealized.
-
Rapid market change: The biopharma landscape was shifting quickly, with clients demanding more integrated, data-driven support across the full product lifecycle. Real Chemistry needed a strategy that could keep pace with a market evolving faster than its internal structures.
-
Stakeholder alignment complexity: Bringing a senior leadership team representing diverse business units into alignment on a shared vision and roadmap required structured facilitation and a clear framework for decision-making.
-
Sustaining 20+ years of growth: Real Chemistry's track record of growth created high expectations. Any strategic shift needed to protect and build on existing momentum while unlocking the next stage of scale.
Our Approach
C\R Strategy Partners applied its Aligned Innovation framework to help Real Chemistry develop a unified solutions roadmap, while grounding every strategic decision in market insight and leadership alignment.
C\R structured the engagement in four phases:
-
Research – Conduct stakeholder interviews and market analysis to surface the unmet needs of biopharma clients and map the gap between Real Chemistry's existing capabilities and the integrated offering the market demands.
-
Roadmap – Translate market and organizational insights into a unified solutions roadmap—defining how Real Chemistry's capabilities fit together and how integrated offerings can be brought to clients more effectively.
-
Structure – Develop the operating structures, processes, and frameworks needed to deliver on the roadmap—establishing shared definitions, cross-unit collaboration models, and a centralized leadership architecture.
-
Alignment – Facilitate a three-day executive offsite to align Real Chemistry's senior leadership team around the roadmap and equip them to drive execution across the organization.
Learning & Outcomes
The engagement shifted Real Chemistry's internal alignment and external positioning at the same time, producing durable outcomes across the organization:
-
Executive alignment: Real Chemistry's senior leadership team reached consensus around a shared vision and strategic roadmap, by establishing a common language and direction across previously siloed business units.
-
Integrated capabilities: A new solutions framework defined how Real Chemistry's diverse capabilities connect and complement one another, making it possible to bring a truly integrated offering to biopharma clients.
-
Shared processes: Cross-functional collaboration models and shared operating processes gave teams across the organization a structured way to work together toward common client and business outcomes.
-
Market focus: A sharpened understanding of the biopharma market's evolving demands gave leadership the clarity to prioritize where to invest and how to position Real Chemistry's integrated platform for growth.
-
Leadership development: The three-day executive offsite built not just alignment but capability, giving Real Chemistry's leaders the frameworks and confidence to continue driving the strategy internally after the engagement concluded.
-
Scalable structure: A centralized leadership team and integrated operating model gave Real Chemistry the organizational foundation to scale its unified platform efficiently as the business continues to grow.
The Results
The Real Chemistry engagement moved the organization, and fast. In six weeks, it produced:
-
Unified roadmap in 6 weeks: Real Chemistry's integrated solutions roadmap was developed and aligned in under six weeks: translating complex organizational and market analysis into a clear, actionable strategy with executive buy-in.
-
Three-day executive offsite delivered: A structured three-day offsite brought Real Chemistry's senior leadership team into full alignment around the new roadmap, creating shared ownership and a foundation for coordinated execution.
-
Centralized leadership team formed: Real Chemistry established a centralized leadership structure to drive the integrated strategy. Breaking down silos and creating the organizational clarity needed to deliver on the platform's promise.
-
Integrated solutions framework defined: A new solutions architecture gave Real Chemistry a coherent way to position and deliver its full range of capabilities, enabling a more compelling, integrated client experience across the biopharma lifecycle.
-
Positioned for continued growth: A refined market strategy, aligned leadership team, and integrated operating model gave Real Chemistry the foundation to protect its 20+ year growth trajectory and pursue the next stage of scale.
Real Chemistry now has the roadmap, the leadership alignment, and the processes to bring its full capabilities to bear for biopharma clients; and to keep building for what's next.